Unknown NA INTERVENTIONAL 1-arm NCT05365191

A Study Evaluating Near-infrared Zone II Imaging in Sentinel Lymph Node Mapping in Breast Cancer Patients

Development and Utilization of Indocyanine Green Fluorescence Near Infrared Zone II Lymphography in Breast Cancer Patients

Sponsor: National Taiwan University Hospital Hsin-Chu Branch

Conditions Breast Cancer Sentinel Lymph Node

Interventions Near infrared fluorescence navigated sentinel lymph node mapping

Updated 4 times since 2022 Last updated: May 6, 2022 Started: Apr 8, 2022 Primary completion: Apr 7, 2023 Completion: Apr 7, 2023

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Breast Cancer and Sentinel Lymph Node and is currently ongoing. National Taiwan University Hospital Hsin-Chu Branch leads this study, which shows 4 recorded versions since 2022 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Unknown NA
Jul 2024 — Sep 2024 [monthly]

Unknown NA

Status: Unknown Status → Unknown
Jun 2024 — Jul 2024 [monthly]

Unknown Status NA

Status: Recruiting → Unknown Status
Jun 2022 — Jun 2024 [monthly]

Recruiting NA

First recorded

Apr 2022

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

National Taiwan University Hospital Hsin-Chu Branch
National Yang Ming Chiao Tung University

Data source: National Taiwan University Hospital Hsin-Chu Branch

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Zhubei, Taiwan